Effect of rifampin on the immune response in mice.
In an investigation of the effect of rifampin on the immune response in mice, the cellular immunity was evaluated with the split-heart allograft technique. The survival time of the heart in animals treated with rifampin at a dose of 20 mg/kg per day from the day of the transplantation until the graft was rejected was longer (33.7 days, P less than 0.001) than that of animals not treated with antibiotics (14.5 days). When rifampin was given at a dose of 5 mg/kg per day for the same period, the mean survival time of allografts was 19.5 days. The number of demonstrable plaques of hemolysis and the humoral antibodies to sheep erythrocytes were also reduced by a human therapeutic dose (20 mg/kg per day). However, the suppression of the humoral immune response was probably of more limited biological significane, suggesting a differential sensitivity to rifampin. In contrast to rifampin, benzylpenicillin had no noteworthy inhibiting effect on the cellular or humoral immune response.
D000373:Agglutinins / Q000032:analysis; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000921:Antibody-Producing Cells / Q000187:drug effects*; D006462:Hemolytic Plaque Technique; D007111:Immunity, Cellular / Q000187:drug effects; D051379:Mice; D012293:Rifampin / Q000097:blood / Q000494:pharmacology* / Q000633:toxicity; D013154:Spleen / Q000187:drug effects / Q000276:immunology
D000373:Agglutinins; D012293:Rifampin